Article
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Neutral
0.0
−100 Bearish
0
+100 Bullish
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This